IDL Biotech AB operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IDL Biotech AB with three other
pharmaceutical manufacturers in Europe:
RTA Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret AS
sales of 38.45 million Turkish Liras [US$6.02 million]
Hemcheck Sweden AB
(10,000.00 Swedish Kronor [US$1,122.50 ]
based in Germany
(1.86 million Euro [US$2.18 million]
of which 68%
IDL Biotech AB reported sales of SEK 32.31 million (US$3.63 million)
December of 2017.
decrease of 3.5%
versus 2016, when the company's sales were SEK 33.49 million.